Sign inJoin waitlistJoin the waitlist

Frances Austin

Assistant Professor · Virginia Commonwealth University Health System

Credentials: · · ·

History

Virginia Commonwealth University Health System
Present

Hematology and Medical Oncology
2014–2017
Pediatrics
Tower Health
2011–2014
Drexel University College of Medicine
2003–2007

Research

De novo CIAS1 mutations, cytokine activation, and evidence for genetic heterogeneity in patients with neonatal-onset multisystem inflammatory disease (NOMID): a new member of the…
Arthritis & Rheumatism · 2002 · 591 citations
The clinical continuum of cryopyrinopathies: novel CIAS1 mutations in North American patients and a new cryopyrin model
Arthritis & Rheumatism · 2007 · 305 citations
Malignant peritoneal mesothelioma: prognostic factors and oncologic outcome analysis
Annals of Surgical Oncology · 2014 · 84 citations

David Bartlett
9 papers
MS
Magesh Sathaiah
7 papers · 5 as a resident
Herbert Zeh
5 papers
James Pingpank
5 papers
Matthew Holtzman
5 papers
Mohammad Choudry
5 papers
Steven Ahrendt
5 papers
Amer Zureikat
4 papers
Arun Mavanur
4 papers
Patrick Wagner
3 papers · 2 as a fellow
Pragatheeshwar Thirunavukarasu
3 papers · 3 as a resident
Deepa Magge
2 papers · 2 as a resident

Clinical trials

A Study Using Risk Factors to Determine Treatment for Children With Favorable Histology Wilms Tumors (FHWT)
Site PI · Recruiting · Phase 3
Children's Oncology Group
2025–2031
Chemotherapy for the Treatment of Patients With Newly Diagnosed Very Low-Risk and Low Risk Fusion Negative Rhabdomyosarcoma
Site PI · Recruiting · Phase 3
Children's Oncology Group
2022–2030
A Study of Combination Chemotherapy for Patients With Newly Diagnosed DAWT and Relapsed FHWT
Site PI · Recruiting · Phase 2
Children's Oncology Group
2020–2027
Active Surveillance, Bleomycin, Etoposide, Carboplatin or Cisplatin in Treating Pediatric and Adult Patients With Germ Cell Tumors
Site PI · Recruiting · Phase 3
Children's Oncology Group
2017–2027